On May 24th, 2FIRSTS, an electronic cigarette vendor in Russia, noticed that the Vardex online retail platform had changed its method for displaying "tracing labels". Products registered with the "tracing label" would no longer receive individual labels, but rather have them displayed collectively at the bottom of the website. In response, the 2FIRSTS Moscow news team interviewed a representative from BABYLON, the parent company of Vardex, for their perspective on the matter.
Babylon is one of the largest electronic cigarette dealers in Russia. Vardex is their online sales platform for electronic cigarettes and they represent well-known brands such as ELFBAR, LOSTMARY, and NOKO.
The responsible staff at BABYLON have informed 2FIRSTS that Vardex is undergoing a comprehensive compliance overhaul and will only sell products that have been registered with a "Tracing Label". The spokesperson explained that Vardex is currently removing products that have not been registered with the label and adjusting its website by prominently displaying the "Honesty Label" at the bottom of the page, instead of selling products with and without the label as it previously did.
Furthermore, 2FIRSTS has discovered notices on the Vardex website announcing the closure of several brick-and-mortar stores. In response, a spokesperson for BABYLON stated that this is a normal business adjustment and the closures are due to poor performance of those specific stores. BABYLON has also added new stores in high-potential consumer areas.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
